FR2668061A1 - Cosmetic compositions for application around the eyes - Google Patents
Cosmetic compositions for application around the eyes Download PDFInfo
- Publication number
- FR2668061A1 FR2668061A1 FR9012988A FR9012988A FR2668061A1 FR 2668061 A1 FR2668061 A1 FR 2668061A1 FR 9012988 A FR9012988 A FR 9012988A FR 9012988 A FR9012988 A FR 9012988A FR 2668061 A1 FR2668061 A1 FR 2668061A1
- Authority
- FR
- France
- Prior art keywords
- composition according
- eyes
- extract
- seroproteins
- mucopolysaccharides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
La présente invention a pour objet de nouvelles compositions cosmétiques trouvant tout particulièrement leur application au contour des yeux. The present invention relates to new cosmetic compositions which find their application particularly to the eye area.
Cette partie essentielle du visage a de tout temps été l'objet d'attentions précises et vigilantes, mais trop souvent, les produits utilisés encore actuellement relèvent du maquillage pur et servent alors de camouflage à des anomalies qui subsistent sous la couche de produit et reparaissent progressivement au fur et à mesure de l'effacement de cette couche. This essential part of the face has always been the object of precise and vigilant attention, but too often, the products still used today are pure make-up and then serve as camouflage for anomalies which remain under the product layer and reappear gradually as this layer is erased.
Plutôt que de cacher, on a cherché depuis quelques années à aborder directement les problèmes par des soins plus spécialisés. En fait, la complexité de ces problèmes et le nombre des phénomènes et paramètres qu'ils impliquent ont abouti à des solutions soit très incomplètes et inefficaces, soit très compliquées et coûteuses, soit parfois même désastreuses, par manque d'étude et d'expérimentation, par inadéquation avec certains types de sujets, c' est-à-dire, pour résumer, par défaut de technicité. Rather than hiding, efforts have been made in recent years to address the problems directly with more specialized care. In fact, the complexity of these problems and the number of phenomena and parameters they imply have led to solutions that are either very incomplete and ineffective, very complicated and expensive, or sometimes even disastrous, for lack of study and experimentation. , by inadequacy with certain types of subjects, that is to say, to sum up, by lack of technicality.
Si l'on analyse soigneusement les seuls phénomènes les plus généraux et les plus fréquents, et sans tenir compte des aspects esthétiques strictement liés aux couleurs qui peuvent en découler, on constate la présence d'amas graisseux, l'accumulation d'eau, et des anomalies dans le pH et l'isotonocité, c'est-à-dire dans l'équilibre des pressions osmotiques entre, d'une part, l'intérieur et, d'autre part, les produits chargés en substances actives et appliqués extérieurement, intérieur et extérieur étant séparés par la peau qui se comporte en membrane et devrait normalement permettre une compensation en laissant pénétrer les actifs dès qu'un déficit intérieur se produit. If we carefully analyze only the most general and frequent phenomena, and without taking into account the aesthetic aspects strictly related to the colors which can result, we note the presence of fatty deposits, the accumulation of water, and anomalies in the pH and isotonocity, that is to say in the balance of osmotic pressures between, on the one hand, the interior and, on the other hand, the products loaded with active substances and applied externally , interior and exterior being separated by the skin which behaves in a membrane and should normally allow compensation by letting the active ingredients penetrate as soon as an interior deficit occurs.
Pour résumer, on peut considérer que les principales anomalies relèvent de dérèglements physiologiques, parfois temporaires, que l'organisme lui-même devrait pouvoir éliminer, en ramenant les choses vers la normale, mais on se trouve fréquemment en présence d'organismes qui sont incapables soit de surmonter ces difficultés, soit d'apporter des solutions rapides et efficaces. To summarize, we can consider that the main anomalies arise from physiological disturbances, sometimes temporary, that the organism itself should be able to eliminate, by bringing things back to normal, but we are frequently in the presence of organisms that are incapable either overcome these difficulties or provide quick and effective solutions.
La présente invention a donc pour but de suppléer les déficiences totales ou partielles de l'organisme notamment en assurant l'élimination des amas lipidiques, en résorbant l'eau, en particulier celle d'origine oedémateuse,en régulant le pH au voisinage de la neutralité, ainsi que l'isotonicité par action d'autorégulation sur les équilibres osmotiques, et en assurant, par ailleurs, un rôle réparateur et adoucissant pour les tissus, et, de plus, un rôle antiinflammatoire. The present invention therefore aims to supplement the total or partial deficiencies of the organism in particular by ensuring the elimination of lipid clumps, by absorbing water, in particular that of edematous origin, by regulating the pH in the vicinity of neutrality, as well as isotonicity by self-regulating action on the osmotic balances, and ensuring, moreover, a repairing and softening role for the tissues, and, moreover, an anti-inflammatory role.
En ce qui concerne le pH, on rappellera que les bases sont dangereuses pour les yeux et les acides pour la peau et ceci d'autant plus que l'on s'écarte de la neutralité. I1 importe donc de s'en tenir à un pH très voisin de 7 pour éviter tout incident qui pourrait résulter d'un faux mouvement lors de l'application. Regarding the pH, it will be recalled that the bases are dangerous for the eyes and acids for the skin and this all the more that one deviates from neutrality. It is therefore important to stick to a pH very close to 7 to avoid any incident which could result from a false movement during application.
Pour parvenir au but ci-dessus fixé, l'invention fait appel à des associations de composants dont l'expérience a montré les surprenants et bénéfiques effets de synergie. To achieve the above objective, the invention calls upon combinations of components whose experience has shown the surprising and beneficial synergistic effects.
Cette association comprend essentiellement
- de 2 à 8% en poids de mucopolysaccharides de
préférence d'origine marine,
- de 0,5 à 1,5 d'escine
- de 0,3 à 1,2% d'extrait végétal à action
réparatrice et notamment, de centella asiatica,
- et de 0,2 à 1,8% d'extrait animal également à
action réparatrice, et en particulier d'extrait de
cervelle de boeuf.This association essentially includes
- from 2 to 8% by weight of mucopolysaccharides
preferably of marine origin,
- 0.5 to 1.5 steps
- from 0.3 to 1.2% of plant extract with action
restorative and in particular, of centella asiatica,
- and from 0.2 to 1.8% of animal extract also
restorative action, and in particular extract of
beef brains.
L'action de cette association de base peut être renforcée par de la vitamine E et/ou des flavonoïdes (ou vitamine P) eux-mêmes exaltés par ladite vitamine E, et/ou par des séroprotéines, notamment extraites de l'élastine, et/ou de la caféine, et/ou de l'alchémille, et/ou de l'eau de bleuet. The action of this basic association can be reinforced by vitamin E and / or flavonoids (or vitamin P) themselves enhanced by said vitamin E, and / or by seroproteins, in particular extracted from elastin, and / or caffeine, and / or lady's mantle, and / or blueberry water.
L'expérience a démontré que l'action des mucopolysaccharides était considérablement potentialisée par l'escine, ce qui est déjà connu, mais également par l'association avec les flavonoïdes et les séroprotéines, ce qui se traduit par une mobilisation largement accrue des lipides et leur évacuation et une résorption totale des manifestations de type oedémateux. Qui plus est, certains composants connus pour leur action adoucissante ou antiinflammatoire, peuvent renforcer la stabilisation du pH et parfaire l'autorégulation de l'équilibre isotonique amorcée par les autres composants conformes à l'invention: c'est le cas notamment de l'eau de bleuet, qui présente des effets de synergie remarquables avec nombre des autres composés préférés selon l'invention. Experience has shown that the action of mucopolysaccharides is considerably potentiated by escin, which is already known, but also by the association with flavonoids and seroproteins, which results in a greatly increased mobilization of lipids and their evacuation and a total resorption of edematous type manifestations. What is more, certain components known for their softening or anti-inflammatory action can reinforce the stabilization of the pH and perfect the self-regulation of the isotonic balance initiated by the other components in accordance with the invention: this is particularly the case for blueberry water, which exhibits remarkable synergistic effects with a number of the other preferred compounds according to the invention.
Pour mieux faire comprendre les caractéristiques techniques et les avantages de la présente invention, on va en décrire un exemple de réalisation étant bien entendu que celui-ci n'est pas limitatif quant à son mode de mise en oeuvre et aux applications qu'on peut en faire. To better understand the technical characteristics and the advantages of the present invention, an embodiment will be described, it being understood that this is not limiting as to its mode of implementation and to the applications that can be make it.
On se basera sur la composition pondérale suivante:
Phase A - alphatocophérol (vitamine E) 0,50% - cire d'abeille 2,00% - acétate de l'éther propylèneglycolique
de l'alcool isocétylique 5,00% - huile de cynorrhodon décolorée 3,00% - mica + sulfate de baryum + dioxyde
de titane 1,50%
Phase B - eau déminéralisée 42,09% - polyglycane 0,60% - polyacrylate de glycérol 20,00% - triéthanolamine à 99% 0,85% - escine 1,00%
Phase C - liposomes 5,00% - extrait de cervelle de boeuf 1,00% - centella asiatica (macérat dans le
propylène-glycol) 0,50% - mucopolysaccharides 5,00% - séroprotéines structurées à 4%
extraites de l'éîastine 2,00% - extrait d'alchémille dans l'eau
et le glycol 1,00% - eau de bleuet 5,00% - caféine 0,70% - sorbitol 1,00% - complexe naturel de bioflavonoïdes (vit.P) 0,10% - chlorure de sodium 0,90% - dihydrogénophosphate de potassium 0,01%
- alcool benzylique + méthylchlorothiazo
- linone + méthylisothiazolinone 0,25%
- eau déminéralisée 1,00%
colorant pour mémoire
On prépare la phase C par dissolution des produits pulvérulents dans la phase liquide.We will use the following weight composition:
Phase A - alphatocopherol (vitamin E) 0.50% - beeswax 2.00% - acetylene glycol ether acetate
isocetyl alcohol 5.00% - discolored rose hip oil 3.00% - mica + barium sulfate + dioxide
1.50% titanium
Phase B - demineralized water 42.09% - polyglycan 0.60% - glycerol polyacrylate 20.00% - triethanolamine 99% 0.85% - escine 1.00%
Phase C - liposomes 5.00% - beef brain extract 1.00% - centella asiatica (macerate in the
propylene glycol) 0.50% - mucopolysaccharides 5.00% - 4% structured seroproteins
extracted from eîastine 2.00% - alchemilla extract in water
and glycol 1.00% - blueberry water 5.00% - caffeine 0.70% - sorbitol 1.00% - natural complex of bioflavonoids (vit.P) 0.10% - sodium chloride 0.90% - potassium dihydrogen phosphate 0.01%
- benzyl alcohol + methylchlorothiazo
- linone + methylisothiazolinone 0.25%
- demineralized water 1.00%
dye for memory
Phase C is prepared by dissolving the pulverulent products in the liquid phase.
Par ailleurs, on dissout, sous agitation l'escine et le polyglycane dans l'eau de la phase B et on homogénéise; on ajoute la diéthanolamine et on chauffe à 750C; on ajoute le polyacrylate de glycérol et on poursuit l'homogénéisation. Furthermore, the escin and the polyglycan are dissolved, with stirring, in the water of phase B and homogenized; diethanolamine is added and the mixture is heated to 750C; the glycerol polyacrylate is added and the homogenization is continued.
On réalise la phase A également à 750C puis on l'incorpore dans la phase B sous agitation modérée jusqu'à homogénéité. On laisse refroidir lentement sous agitation modérée jusque vers 380C et on ajoute la phase C toujours sous agitation en laissant progressivement refroidir à la température ambiante. Phase A is also carried out at 750C and then incorporated into phase B with moderate stirring until homogeneous. It is allowed to cool slowly with moderate stirring until around 380C and phase C is added, still with stirring, while gradually allowing it to cool to room temperature.
On obtient une crème à pH de 7,1 et d'une viscosité de 8 poises. A cream with a pH of 7.1 and a viscosity of 8 poises is obtained.
Cette crème a été testée dans les conditions suivantes
on a appliqué quotidiennement pendant dix jours ladite crème du côté de l'oeil droit de cent sujets (85 femmes et 15 hommes) de 35 à 65 ans, et, du côté de l'oeil gauche de ces mêmes sujets, une crème classique du commerce.This cream has been tested under the following conditions
said cream was applied daily for ten days to the side of the right eye of one hundred subjects (85 women and 15 men) aged 35 to 65, and to the side of the left eye of these same subjects, a classic cream of the trade.
Les sujets ont été sélectionnés au fur et à mesure où ils se présentaient, quand ils présentaient au moins l'une des deux caractéristiques suivantes
"poches" sous les yeux avec gonflement anormal,
- flétrissures importantes (rides et /ou cernes).Subjects were selected as they appeared, when they exhibited at least one of the following two characteristics
"bags" under the eyes with abnormal swelling,
- significant wilting (wrinkles and / or dark circles).
A l'issue des dix jours, on a évalué respectivement la résorption du gonflement et la réduction des plis. Le relief cutané a été observé par la méthode de MAKKI (MAKKI
S.,BARBENEL J.C. Acta Dermatovener 1979,30/ 213-239) à l'aide d'un appareil analyseur d'image de peau à caméra numérique associée à un microcalculateur, à partir d'empreinte faite en caoutchouc au silicone de type "silflo" sur la surface au repos sans hypersudation, ni dégraissage, ni rasage.After ten days, the resorption of the swelling and the reduction of the folds were evaluated respectively. The skin relief was observed by the MAKKI method (MAKKI
S., BARBENEL JC Acta Dermatovener 1979,30 / 213-239) using a skin image analyzer with digital camera associated with a microcomputer, from an impression made of silicone rubber of the " silflo "on the surface at rest without sweating, degreasing or shaving.
On a pu ainsi constater une résorption totale des poches chez 38% des sujets qui en présentaient et une amélioration importante chez 58% d'entre eux. Par ailleurs, une réduction relative très importante des plis (plus de 25% de la profondeur en moyenne, et diminution de plus de 18% en moyenne de la rugosité) a été constatée chez 71% de l'ensemble des sujets et très appréciable chez 21% d'entre eux. We could thus observe a total absorption of bags in 38% of the subjects who had them and a significant improvement in 58% of them. In addition, a very significant relative reduction in folds (more than 25% on average in depth, and reduction of more than 18% on average in roughness) was observed in 71% of all subjects and very appreciable in 21% of them.
En ce qui concerne la tolérance et l'innocuité, seuls, un sujet du sexe masculin a présenté des rougeurs pendant la durée du traitement et ont disparu deux jours après, et un autre du sexe féminin, des rougeurs qui ont disparu après la sixième application. Regarding tolerance and safety, only one male subject experienced redness during treatment and disappeared two days later, and another female subject, redness which disappeared after the sixth application. .
Par contre du côté de la crème du commerce, les résultats ont été nettement moins favorables, ce qui s'est traduit par une réduction nettement plus faible des gonflements et des flétrissures et un nombre six fois plus important de cas d'intolérance. On the other hand, on the commercial cream side, the results were clearly less favorable, which resulted in a much smaller reduction in swelling and wilting and a six times greater number of cases of intolerance.
On a également procédé à des observations sur 50 clientes volontaires en instituts de beauté qui ont appliqué ledit produit conforme à l'invention au lever et au coucher pendant un mois. On a observé des résultats positifs ou très positifs dans les cas suivants
- tolérance au produit 98%
- action rafraîchissante et/ou calmante 79%
- atténuation des poches 51%
- atténuation des cernes 59%
Au vu de ces résultats, on peut donc considérer que la présente invention apporte des progrès substantiels, de sorte que l'homme de l'art pourra choisir de nombreuses variantes dans le cadre de l'invention et sans s'en départir. Observations were also made on 50 volunteer clients in beauty salons who applied the product in accordance with the invention to getting up and going to bed for a month. Positive or very positive results have been observed in the following cases
- 98% product tolerance
- refreshing and / or calming action 79%
- pocket reduction 51%
- reduction of dark circles 59%
In view of these results, it can therefore be considered that the present invention provides substantial progress, so that those skilled in the art will be able to choose many variants within the scope of the invention and without departing from it.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9012988A FR2668061A1 (en) | 1990-10-19 | 1990-10-19 | Cosmetic compositions for application around the eyes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9012988A FR2668061A1 (en) | 1990-10-19 | 1990-10-19 | Cosmetic compositions for application around the eyes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2668061A1 true FR2668061A1 (en) | 1992-04-24 |
| FR2668061B1 FR2668061B1 (en) | 1994-12-16 |
Family
ID=9401411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9012988A Granted FR2668061A1 (en) | 1990-10-19 | 1990-10-19 | Cosmetic compositions for application around the eyes |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2668061A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2755012A1 (en) * | 1996-10-31 | 1998-04-30 | Slow Age Creations | Cosmetic compositions to reduce pre-menstrual mammary tension |
| WO1998025585A1 (en) * | 1996-12-11 | 1998-06-18 | Henkel Kommanditgesellschaft Auf Aktien | Skin protecting agent |
| WO2000069408A1 (en) * | 1999-05-18 | 2000-11-23 | The Procter & Gamble Company | Methods of regulating the condition of mammalian keratinous tissue |
| WO2001019365A1 (en) * | 1999-09-15 | 2001-03-22 | Roche Consumer Health Ag | Pharmaceutical and/or cosmetical compositions |
| EP1090629A1 (en) * | 1999-10-08 | 2001-04-11 | L'oreal | Aescin and dextran sulfate association |
| FR2895257A1 (en) * | 2005-12-22 | 2007-06-29 | Oreal | Use of lipophilic antioxidant as active principle for preparing cosmetic and/or dermatological composition to maintain and/or reinforce the protective and reparative native function of lipophilic structures of eye contour |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1433383A (en) * | 1965-01-08 | 1966-04-01 | Laroche Navarron Lab | Cosmetic composition for the maintenance and regeneration of the dermis |
| EP0022046A1 (en) * | 1979-06-25 | 1981-01-07 | ETABLISSEMENT RINRONE (Société de droit du Liechtenstein) | Drug composition based on plants and process for its preparation |
| WO1981000514A1 (en) * | 1979-08-20 | 1981-03-05 | J Thorel | New slimming compositions |
| DE3535084A1 (en) * | 1985-10-02 | 1987-04-09 | Roshdy Ismail | Skin-protection composition |
-
1990
- 1990-10-19 FR FR9012988A patent/FR2668061A1/en active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1433383A (en) * | 1965-01-08 | 1966-04-01 | Laroche Navarron Lab | Cosmetic composition for the maintenance and regeneration of the dermis |
| EP0022046A1 (en) * | 1979-06-25 | 1981-01-07 | ETABLISSEMENT RINRONE (Société de droit du Liechtenstein) | Drug composition based on plants and process for its preparation |
| WO1981000514A1 (en) * | 1979-08-20 | 1981-03-05 | J Thorel | New slimming compositions |
| DE3535084A1 (en) * | 1985-10-02 | 1987-04-09 | Roshdy Ismail | Skin-protection composition |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2755012A1 (en) * | 1996-10-31 | 1998-04-30 | Slow Age Creations | Cosmetic compositions to reduce pre-menstrual mammary tension |
| WO1998025585A1 (en) * | 1996-12-11 | 1998-06-18 | Henkel Kommanditgesellschaft Auf Aktien | Skin protecting agent |
| WO2000069408A1 (en) * | 1999-05-18 | 2000-11-23 | The Procter & Gamble Company | Methods of regulating the condition of mammalian keratinous tissue |
| WO2001019365A1 (en) * | 1999-09-15 | 2001-03-22 | Roche Consumer Health Ag | Pharmaceutical and/or cosmetical compositions |
| EP1090629A1 (en) * | 1999-10-08 | 2001-04-11 | L'oreal | Aescin and dextran sulfate association |
| FR2799369A1 (en) * | 1999-10-08 | 2001-04-13 | Oreal | COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF |
| US6562355B1 (en) | 1999-10-08 | 2003-05-13 | Societe L'oreal S.A. | Comixture of dextran sulfate/escin for treating skin redness/edema and/or sensitive skin |
| FR2895257A1 (en) * | 2005-12-22 | 2007-06-29 | Oreal | Use of lipophilic antioxidant as active principle for preparing cosmetic and/or dermatological composition to maintain and/or reinforce the protective and reparative native function of lipophilic structures of eye contour |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2668061B1 (en) | 1994-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11335233A (en) | Melanogenesis inhibitor and cosmetic composition | |
| BE1010042A3 (en) | USE OF AN EXTRACT loquat, PARTICULARLY IN THE FIELD OF COSMETICS, TO STIMULATE THE SUMMARY OF GLYCOSAMINOGLYCANS. | |
| JPH11246336A (en) | Activated oxygen scavenger and skin beautifying cosmetic composition | |
| JP2002205933A (en) | Cosmetic composition containing extract of orchidaceous plant | |
| JP2001039823A (en) | Cosmetic composition containing humectant plant extract | |
| JP2008050312A (en) | Skin tone concealer for use in cosmetic and cosmetic containing the same | |
| JP2000247897A (en) | Cosmetic composition | |
| FR2668061A1 (en) | Cosmetic compositions for application around the eyes | |
| CA2189161C (en) | Hair dye composition containing ground plants or portions of plants of the species impatiens balsamina, and application thereof | |
| WO1992021322A1 (en) | Cosmetic or pharmaceutical, particularly dermatological, composition containing a prunella extract | |
| JP2001031552A (en) | Cosmetic composition containing moisture-retaining plant extract | |
| JP2001081037A (en) | Cosmetic composition | |
| WO2012045974A2 (en) | Cosmetic use of a tropaeolum majus extract as an active principle for promoting the oxygenation of skin tissue | |
| JP2000229835A (en) | Cosmetic material for improving dullness | |
| JP2000226322A (en) | Agar or sodium alginate granule-containing cosmetic composition | |
| CN109276514A (en) | A kind of novel Face-protecting mask and preparation method thereof of releiving | |
| WO2003066101A1 (en) | Preparation for oxidation-sensitive compounds and method for making same | |
| FR3062061A1 (en) | ARTIFICIAL SEBUM AND METHOD FOR MANUFACTURING ARTIFICIAL SEBUM | |
| FR2685867A1 (en) | Compositions for combatting desquamation of the epidermis and scalp | |
| FR2634120A1 (en) | NEW COSMETIC COMPOSITIONS BASED ON CHROMONE-CARBOXYLATES | |
| EP0519777A1 (en) | Galenical forms based on fresh or dried plants | |
| FR2893846A1 (en) | Use of a composition containing ecdysteroid or its derivative, or vegetable/animal extracts to stimulate natural defenses of the cells against the consequences of their exposure to UV radiations | |
| FR2780277A1 (en) | Use of lipid extracts from mirabelle tree seeds in cosmetics for skin, hair etc | |
| CH686999A5 (en) | Cosmetic skin care compsn. for combating effects of stress and ageing | |
| JP2000109420A (en) | Cosmetic against aging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CL | Concession to grant licences | ||
| CL | Concession to grant licences | ||
| CL | Concession to grant licences | ||
| AU | Other action affecting the ownership or exploitation of an industrial property right | ||
| ST | Notification of lapse |
Effective date: 20090630 |